Resveratrol Improves Hepatic Redox Status and Lipid Balance of Neonates with Intrauterine Growth Retardation in a Piglet Model

Biomed Res Int. 2020 Jul 18:2020:7402645. doi: 10.1155/2020/7402645. eCollection 2020.

Abstract

Abnormal lipid metabolism, oxidative stress (OS), and inflammation play a pivotal role in the increased susceptibility to neonatal fatty liver diseases associated with intrauterine growth retardation (IUGR). This study was firstly conducted to investigate whether resveratrol could alleviate IUGR-induced hepatic lipid accumulation, alteration of redox and immune status in a sucking piglet model and explore the possible mechanisms at transcriptional levels. A total of 36 pairs of 7 d old male normal birth weight (NBW) and IUGR piglets were orally fed with either 80 mg resveratrol/kg body weight/d or 0.5% carboxymethylcellulose sodium for a period of 14 days, respectively. Compared with the NBW piglets, the IUGR piglets displayed compromised growth performance and liver weight, reduced plasma free fatty acid (FFA) level, increased hepatic OS, abnormal hepatic lipid accumulation and weakened hepatic immune function, and hepatic aberrant transcriptional expression of some genes such as heme oxygenase 1, superoxide dismutase 1, sterol regulatory element-binding protein 1c, stearoyl-CoA desaturase 1, liver fatty acid-binding proteins 1, toll-like receptor 4, and tumor necrosis factor alpha (TNF-α). Oral administration of resveratrol to piglets decreased the levels of FFA and total triglycerides (TG) in the plasma and hepatic TNF-α concentration, and increased glutathione reductase activity and reduced glutathione level in the liver. Resveratrol restored the increased alanine aminotransferase activity in the plasma of IUGR piglets. Treatment with resveratrol ameliorated the increased hepatic malondialdehyde, protein carbonyl, TG, and FFA concentrations induced by IUGR. Resveratrol treatment alleviated the reduced lipoprotein lipase activity and its mRNA expression as well as TNF-α gene expression in the liver of IUGR piglets. Hepatic glutathione peroxidase 1 and monocyte chemotactic protein 1 genes expression of piglets was upregulated by oral resveratrol administration. In conclusion, resveratrol administration plays a beneficial role in hepatic redox status and lipid balance of the IUGR piglets.

MeSH terms

  • Animals
  • Animals, Newborn
  • Antioxidants / metabolism
  • Blood Circulation / drug effects
  • Disease Models, Animal
  • Fetal Growth Retardation / drug therapy*
  • Fetal Growth Retardation / metabolism*
  • Gene Expression Regulation / drug effects
  • Glycolipids / metabolism
  • Lipid Metabolism / drug effects*
  • Lipid Metabolism / genetics
  • Liver / drug effects
  • Liver / immunology
  • Liver / metabolism*
  • Oxidation-Reduction
  • Resveratrol / pharmacology
  • Resveratrol / therapeutic use*
  • Swine
  • Transaminases / blood
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antioxidants
  • Glycolipids
  • Tumor Necrosis Factor-alpha
  • Transaminases
  • Resveratrol